DE69231567D1 - Screeningverfahren von morphogenischen Proteinen - Google Patents
Screeningverfahren von morphogenischen ProteinenInfo
- Publication number
- DE69231567D1 DE69231567D1 DE69231567T DE69231567T DE69231567D1 DE 69231567 D1 DE69231567 D1 DE 69231567D1 DE 69231567 T DE69231567 T DE 69231567T DE 69231567 T DE69231567 T DE 69231567T DE 69231567 D1 DE69231567 D1 DE 69231567D1
- Authority
- DE
- Germany
- Prior art keywords
- gene
- expression
- epithelial cells
- compound
- level
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
- C07K14/625—Extraction from natural sources
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5058—Neurological cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/475—Assays involving growth factors
- G01N2333/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/10—Screening for compounds of potential therapeutic value involving cells
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US75286191A | 1991-08-30 | 1991-08-30 | |
PCT/US1992/007359 WO1993005172A1 (en) | 1991-08-30 | 1992-08-28 | Morphogenic protein screening method |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69231567D1 true DE69231567D1 (de) | 2000-12-21 |
DE69231567T2 DE69231567T2 (de) | 2001-06-28 |
Family
ID=25028180
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69231567T Expired - Fee Related DE69231567T2 (de) | 1991-08-30 | 1992-08-28 | Screeningverfahren von morphogenischen Proteinen |
Country Status (8)
Country | Link |
---|---|
EP (3) | EP0601129B1 (de) |
JP (3) | JP3616089B2 (de) |
AT (1) | ATE197611T1 (de) |
AU (1) | AU678345B2 (de) |
CA (1) | CA2116560C (de) |
DE (1) | DE69231567T2 (de) |
ES (1) | ES2156862T3 (de) |
WO (1) | WO1993005172A1 (de) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6071695A (en) * | 1992-02-21 | 2000-06-06 | Creative Biomolecules, Inc. | Methods and products for identification of modulators of osteogenic protein-1 gene expression |
AU1180195A (en) * | 1993-11-16 | 1995-06-06 | Children's Medical Center Corporation | Method of identifying a substance capable of inducing bone formation |
JPH10511840A (ja) | 1994-04-29 | 1998-11-17 | クリエイティブ バイオモレキュールズ,インコーポレイテッド | 形態形成タンパク質特異細胞表面レセプターおよびその使用 |
JPH10505223A (ja) * | 1994-06-07 | 1998-05-26 | クリエイティブ バイオモレキュールズ, インコーポレイテッド | 形態形成タンパク質発現を調節するための方法および組成物 |
US20030167492A1 (en) | 1994-07-08 | 2003-09-04 | Johns Hopkins University School Of Medicine | Transgenic non-human animals expressing a gdf-11 dominant negative polypeptide, and methods of making and using same |
US6103491A (en) * | 1995-07-26 | 2000-08-15 | Creative Biomolecules, Inc. | Methods and compositions for identifying morphogen analogs |
US6090544A (en) * | 1995-07-26 | 2000-07-18 | Creative Biomolecules, Inc. | Methods and compositions for identifying morphogen analogs |
US7306903B1 (en) | 1995-07-26 | 2007-12-11 | Curis, Inc. | Methods and compositions for identifying morphogen analogs |
EP0845006A2 (de) * | 1995-08-14 | 1998-06-03 | Creative Biomolecules, Inc. | Bindung des osteogenen proteins-i (op-1) und dessen analoge an den zelloberflächenrezeptor alk-1 und dessen analoge |
KR20000064752A (ko) | 1996-03-22 | 2000-11-06 | 더 제네랄 호스피탈 코포레이션 | 중추신경계허혈또는외상의발현후폴리펩티드성장인자를투여하는방법 |
US6498142B1 (en) | 1996-05-06 | 2002-12-24 | Curis, Inc. | Morphogen treatment for chronic renal failure |
US5928940A (en) * | 1996-09-24 | 1999-07-27 | Creative Biomolecules, Inc. | Morphogen-responsive signal transducer and methods of use thereof |
ATE278414T1 (de) | 1997-05-05 | 2004-10-15 | Curis Inc | Therapien zur behandlung von akutem nierenversagen |
EP2309261A1 (de) * | 1997-05-30 | 2011-04-13 | Stryker Corporation | Verfahren zur Beurteilung von Gewebemorphogenese und- aktivität |
US7147839B2 (en) | 1998-05-29 | 2006-12-12 | Curis, Inc. | Methods for evaluating tissue morphogenesis and activity |
US6524797B1 (en) | 1999-05-10 | 2003-02-25 | Bernhard O. Palsson | Methods of identifying therapeutic compounds in a genetically defined setting |
JP2011514331A (ja) | 2008-02-13 | 2011-05-06 | キース フルスカ, | 血管硬化症の治療における使用のためのbmp−7 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4980281A (en) * | 1988-02-10 | 1990-12-25 | Housey Gerard M | Method of screening for protein inhibitors and activators |
JPH03505669A (ja) * | 1988-07-08 | 1991-12-12 | ユニバーシテイ・カレツジ・ロンドン | バイオアツセイにおける改良 |
EP0429570B1 (de) * | 1989-03-28 | 1998-01-14 | Genetics Institute, Inc. | Osteoinduktive zusammensetzungen |
EP0489062A4 (en) * | 1989-08-21 | 1992-08-12 | Celtrix Laboratories, Inc. | Bone-specific protein |
WO1992015323A1 (en) * | 1991-03-11 | 1992-09-17 | Creative Biomolecules, Inc. | Protein-induced morphogenesis |
-
1992
- 1992-08-28 EP EP92921799A patent/EP0601129B1/de not_active Expired - Lifetime
- 1992-08-28 EP EP97202681A patent/EP0825442A3/de not_active Ceased
- 1992-08-28 WO PCT/US1992/007359 patent/WO1993005172A1/en active IP Right Grant
- 1992-08-28 CA CA002116560A patent/CA2116560C/en not_active Expired - Fee Related
- 1992-08-28 ES ES92921799T patent/ES2156862T3/es not_active Expired - Lifetime
- 1992-08-28 AT AT92921799T patent/ATE197611T1/de not_active IP Right Cessation
- 1992-08-28 JP JP50534593A patent/JP3616089B2/ja not_active Expired - Fee Related
- 1992-08-28 DE DE69231567T patent/DE69231567T2/de not_active Expired - Fee Related
- 1992-08-28 EP EP00100232A patent/EP1033574A3/de not_active Withdrawn
- 1992-08-28 AU AU28624/92A patent/AU678345B2/en not_active Ceased
-
2003
- 2003-01-23 JP JP2003014941A patent/JP2004069670A/ja active Pending
-
2004
- 2004-03-24 JP JP2004087203A patent/JP2004267211A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
CA2116560A1 (en) | 1993-03-18 |
EP0825442A2 (de) | 1998-02-25 |
JP2004267211A (ja) | 2004-09-30 |
DE69231567T2 (de) | 2001-06-28 |
EP0601129A1 (de) | 1994-06-15 |
EP0601129B1 (de) | 2000-11-15 |
AU2862492A (en) | 1993-04-05 |
EP1033574A3 (de) | 2004-01-28 |
WO1993005172A1 (en) | 1993-03-18 |
AU678345B2 (en) | 1997-05-29 |
JP2004069670A (ja) | 2004-03-04 |
JP3616089B2 (ja) | 2005-02-02 |
JPH06510432A (ja) | 1994-11-24 |
CA2116560C (en) | 2002-01-08 |
EP1033574A2 (de) | 2000-09-06 |
ATE197611T1 (de) | 2000-12-15 |
EP0825442A3 (de) | 2004-02-11 |
ES2156862T3 (es) | 2001-08-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE197611T1 (de) | Screeningverfahren von morphogenischen proteinen | |
Reinhard et al. | VASP interaction with vinculin: a recurring theme of interactions with proline‐rich motifs | |
Franke et al. | Differences of expression of cytoskeletal proteins in cultured rat hepatocytes and hepatoma cells | |
Nebgen et al. | Identification of the chondrogenic-inducing activity from bovine dentin (bCIA) as a low-molecular-mass amelogenin polypeptide | |
TIMPL et al. | The aminopropeptide of collagen | |
ATE272109T1 (de) | Rekombinante collagenase typ i aus clostridium histolyticum und ihre verwendung zur isolierung von zellen und zellverbänden | |
ATE352617T1 (de) | Lösliche polypeptidfraktionen des lag-3-proteins; verfahren zur herstellung; therapeutische zusamensetzung; antiidiotypischer antikörper | |
PT670898E (pt) | Polipeptidos de multiplas mutacoes de interleucina-3 (il-3) | |
KR890012000A (ko) | 인간 b세포 자극인자-2에 대한 수용체 단백질 | |
CA2110938A1 (en) | Modified proteins containing controllable intervening sequences and methods of their production | |
CA2206509A1 (en) | Novel hedgehog-derived polypeptides | |
AU6444190A (en) | A polypeptide | |
AU1860395A (en) | Novel human beta 2 integrin alpha subunit | |
US9074175B2 (en) | Method of regenerating elastic fiber with the use of dance or factor enhancing the expression thereof | |
KR960701899A (ko) | 인자 viii:c활성을 갖는 단백질 복합체 및 그의 제조 | |
Cossart | Actin-based bacterial motility: towards a definition of the minimal requirements | |
BR9407512A (pt) | Sequência de ácidos nucléicos vírus recombinante defectivo vetor notadamente virale composição farmaceutica e utilização de uma sequencia de ácidos nucléicos | |
Schor et al. | Substratum-dependent stimulation of fibroblast migration by the gelatin-binding domain of fibronectin | |
ATE197590T1 (de) | Antikoerper spezifisch fur ein haemostatisches protein; seine verwendung zur isolation von intaktem protein; haemostatische zusammensetzungen ohne proteolytische spaltprodukte des proteins | |
CA2345287A1 (en) | Tgf-beta superfamily mutant members, including morphogenic proteins | |
Schaffeld et al. | Type II keratin cDNAs from the rainbow trout: implications for keratin evolution | |
DE69030920T2 (de) | Verfahren zur herstellung von pai-2 | |
Oka et al. | Inductive Influences of Epimorphin on Endothelial Cellsin Vitro | |
Teodoro et al. | Increase of interstitial collagen in the mouse endometrium during decidualization | |
DE69310540D1 (de) | Verhindern von spaltung von n-terminalen aminosäuren durch endogene aminopeptidasen während die expression von fremden genen in bakterien |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |